Is IGF-1 DES FDA approved?
No. This profile records IGF-1 DES as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
IGF-1 DES
THE AMPLIFIER
Des(1-3) IGF-1, IGF-1 DES 1-3
IGF-1 DES is a shortened version of IGF-1 (Insulin-like Growth Factor 1) that's about 10x more potent than regular IGF-1. The "DES" means it's missing the first 3 amino acids, which makes it bind more effectively to receptors and work faster. It's particularly popular for site-specific injections to target lagging muscle groups, as it acts locally rather than systemically.
IGF-1 DES
IGF-1 DES
IGF-1 DES
IGF-1 DES Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
Sources pending
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About IGF-1 DES
What dose does The Peptide App Clinical Team recommend for IGF-1 DES?
Dose: 20-50 mcg per injection site.
MORE CONTEXT ›
Schedule: daily. Cycle: Pre or post-workout, 4-6 week cycles. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this IGF-1 DES guide?
No linked research sources are currently available on this guide.
MORE CONTEXT ›
Treat the profile as provisional until supporting sources are published.
Bodybuilders targeting specific muscle groups
Athletes seeking localized growth
Those who want faster-acting IGF effects
Experienced users of growth factors
IGF-1 DES Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.